Related Experiment Video
Updated: Apr 15, 2026

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
A case of cardiac metastasis from uterine cervical carcinoma
Kazuhiro Okamoto1, Tomoyuki Kusumoto1, Noriko Seki1
1Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikatacho, Kita-ku, Okayama-shi, Okayama 700-8558, Japan.
Insights
Cardiac metastasis from uterine cervical carcinoma is rare, especially before death. This case highlights a rare instance of antemortem cardiac metastasis, indicated by a drop in platelet count, in a patient with advanced cervical cancer.
Area of Science:
- Oncology
- Cardiology
- Pathology
Background:
- Cardiac metastasis from uterine cervical carcinoma is exceptionally rare, with most cases identified only during autopsy.
- Antemortem diagnosis of cardiac metastasis from this malignancy is even rarer.
Purpose of the Study:
- To report a rare case of antemortem cardiac metastasis from uterine cervical carcinoma.
- To emphasize the importance of considering cardiac involvement in terminal cervical cancer patients, particularly when unusual clinical signs emerge.
Main Methods:
- A 27-year-old woman with stage Ib1 uterine cervical carcinoma underwent radical hysterectomy and pelvic lymphadenectomy.
- Positron emission tomography/computed tomography (PET-CT) identified para-aortic lymph node metastasis, leading to adjuvant chemotherapy and subsequent radiation therapy.
- Multidetector CT was used to detect an intracardiac tumor after a significant decrease in platelet count was observed.
Main Results:
- The patient initially responded to chemotherapy, but pelvic lymph node recurrence was suspected.
- A notable decrease in platelet count occurred seven months post-treatment, prompting further investigation.
- Multidetector CT confirmed an intracardiac tumor, representing cardiac metastasis from cervical carcinoma.
Conclusions:
- This case underscores the possibility of antemortem cardiac metastasis from uterine cervical carcinoma, a finding rarely detected before autopsy.
- A declining platelet count can serve as a potential indicator for cardiac metastasis in advanced cervical cancer.
- Clinicians should maintain a high index of suspicion for cardiac involvement in patients with terminal cervical carcinoma presenting with unexplained hematological changes.
Abstract:
Cases of cardiac metastasis from uterine cervical carcinoma are rare. While they are occasionally found on autopsy, antemortem recognition is extremely rare. We confirmed a case of cardiac metastasis from cervical carcinoma antemortem, because we observed a decrease in platelet count during the course of treatment. The patient was a 27-year-old woman diagnosed with stage Ib1 uterine cervical carcinoma. Radical hysterectomy with pelvic lymphadenectomy was performed. Para-aortic lymph node metastasis was detected on positron emission tomography/computed tomography (PET-CT). Adjuvant chemotherapy was started, and most of the metastatic lesions disappeared. Pelvic lymph node recurrence was suspected on PET-CT during continued chemotherapy; therefore, treatment was shifted to radiation therapy. Tumor shrinkage was recognized, and the initial therapy was completed. A noticeable decrease in platelet count was recognized seven months after treatment. Multidetector CT was performed, and an intracardiac tumor was detected. The patient did not desire any further treatment. She died three weeks after the intracardiac tumor was confirmed. Few previous autopsy studies have reported cardiac metastasis from cervical carcinoma. Thus, it is necessary to consider the possibility of cardiac metastasis for patients diagnosed with terminal cervical carcinoma.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis

